← Open Payments lookup

BRANDON AIMAN: Open Payments

NPI 1831124999 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,082 in 103 payments from 21 companies in 2025. Trend: 2023 $2,048 · 2024 $2,123 · 2025 $2,082

Food & beverage: $2,082
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP17$400
GlaxoSmithKline, LLC.23$389
GENZYME CORPORATION8$167
Takeda Pharmaceuticals U.S.A., Inc.6$152
Insmed, Inc.6$115
Verona Pharma, Inc.4$97
Actelion Pharmaceuticals US, Inc.4$81
Regeneron Healthcare Solutions, Inc.3$78
Grifols USA, LLC3$76
Mallinckrodt Hospital Products Inc.3$71

Products named: NUCALA, DUPIXENT, FASENRA, TEZSPIRE, GLASSIA, TRELEGY ELLIPTA, Arikayce, Ohtuvayre.

Industry payments across IN — which companies pay providers there.